Dr Konji Sebati to chair IPASA Board
Dr Konji Sebati, CEO of the Innovative Pharmaceutical Association of South Africa (IPASA), has been appointed non-executive chair of the Independent Agency Search & Selection Company (IAS).
A medical doctor by training, she served as a Medical Officer in Paediatrics and Child Health for several years before managing 21 Primary Health Care clinics in Pretoria.
She joined the private sector working first with Roche as Medical Advisor and then with Pfizer Pharmaceuticals as a senior Executive in Medical and Corporate Affairs, in South Africa and at the Pfizer Headquarters New York.
In 2004 Konji was appointed South Africa’s Ambassador to Switzerland, The Vatican and Liechtenstein, and in 2008 was appointed Ambassador to France, UNESCO and the OECD.
She has also worked as an International Civil Servant, as Senior Director of the United Nations Agency, World Intellectual Property Organisation, based in Geneva, where she headed the Department of Traditional Knowledge and Global Challenges.
In addition to her position at IPASA, she also sits on the Boards of Medicines for Malaria Venture and the Hugh Masekela Heritage Foundation.
Konji has a Bachelor of Science degree from the University of the North (now University of Limpopo), an MBChb degree from University of Nairobi/Kenyatta Hospital, Kenya, a Diploma in Child Health from the College of Medicine, South Africa, and a Diploma in Public Health Planning and Health Services Management from the University of Witwatersrand.